Healthcare Services

Global Rapid Diagnostic Test Kits Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Rapid Diagnostic Test Kits Market Across 2026–2030?

The rapid diagnostic test kits market has experienced robust growth in recent years. This market is projected to expand from $24.08 billion in 2025 to $25.59 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.3%. Historically, this expansion has been driven by factors such as the increasing burden of infectious diseases, the expansion of decentralized healthcare delivery, a rising demand for quick diagnostic results, the growth in outpatient and homecare testing, and the availability of lateral flow and immunoassay technologies.

The rapid diagnostic test kits market is anticipated to show robust expansion over the coming years. It is projected to achieve a size of $32.22 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.9%. This projected growth can be attributed to heightened investments in rapid diagnostic innovation, the increasing uptake of self-testing kits, the broadening of infectious disease surveillance programs, a rising need for affordable diagnostics in emerging markets, and the greater integration of digital readout technologies. Significant trends within this forecast period include the expanding adoption of point-of-care testing solutions, a growing demand for multiplex rapid test kits, an increase in home-based diagnostic testing, the wider availability of portable and disposable test formats, and an intensified focus on early disease detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24678&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Rapid Diagnostic Test Kits Market?

The expanding occurrence of infectious diseases is anticipated to boost the growth of the rapid diagnostic test kits market in the future. Such diseases are defined as ailments resulting from disease-causing microbes like bacteria, viruses, fungi, or parasites, which can spread directly or indirectly among individuals. The escalating incidence of infectious diseases stems from antimicrobial resistance and the evolution of pathogen strains; extensive antibiotic use has led to bacteria resistant to drugs, while viruses constantly mutate, generating new variants that bypass current immunity and necessitate advanced detection techniques. This rise in infectious disease prevalence encourages greater adoption of point-of-care testing tools, facilitating quick pathogen identification. This allows healthcare providers to swiftly diagnose infections, commence suitable treatment, and put in place prompt infection control protocols. For example, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, showing a rise of 1,295 cases. Consequently, the increasing prevalence of infectious diseases is fostering the expansion of the rapid diagnostic test kits market.

What Segmentation Levels Are Considered In The Rapid Diagnostic Test Kits Market?

The rapid diagnostic test kits market covered in this report is segmented –

1) By Product Type: Antigen Test Kits, Antibody Test Kits, Nucleic Acid Test Kits, Multi-Analyte Test Kits

2) By Technology: Fluorescent Immunoassay, Enzyme-Linked Immunosorbent Assay (ELISA), Colloidal Gold-Based Test, Lateral Flow Assays

3) By Application: Infectious Disease Testing, Cardiology Testing, Oncology Testing, Pregnancy And Fertility Testing, Toxicology Testing, Glucose Monitoring, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Home Care Settings, Pharmacies

Subsegments:

1) By Antigen Test Kits: COVID-19 Antigen Test Kits, Influenza Antigen Test Kits, Malaria Antigen Test Kits, Respiratory Syncytial Virus Antigen Test Kits, Streptococcus Antigen Test Kits

2) By Antibody Test Kits: HIV Antibody Test Kits, Hepatitis Antibody Test Kits, COVID-19 Antibody Test Kits, Dengue Antibody Test Kits, Syphilis Antibody Test Kits

3) By Nucleic Acid Test Kits: HIV Nucleic Acid Test Kits, Hepatitis B And C Nucleic Acid Test Kits, Human Papillomavirus Nucleic Acid Test Kits, Tuberculosis Nucleic Acid Test Kits, COVID-19 Nucleic Acid Test Kits

4) By Multi-Analyte Test Kits: Respiratory Panel Test Kits, Sexually Transmitted Infections Panel Test Kits, Gastrointestinal Panel Test Kits, Febrile Illness Panel Test Kits, Sepsis Marker Panel Test Kits

What Trends Are Advancing Progress In The Rapid Diagnostic Test Kits Market?

Leading companies in the rapid diagnostic test kits sector are concentrating on creating innovative solutions, such as saliva-based pregnancy test kits, to enhance their competitive standing. These saliva-based pregnancy test kits function as diagnostic instruments, identifying pregnancy through the analysis of a woman’s saliva for hormonal shifts, specifically human chorionic gonadotropin (hCG), a hormone generated during gestation. As an illustration, in February 2023, Abingdon Health plc, a UK-based near-patient diagnostics firm, introduced Salistick, the inaugural rapid saliva-based pregnancy test available in the UK and Ireland. This marked a notable advancement in at-home pregnancy testing by providing a more hygienic and user-friendly option compared to conventional urine-based tests. This exceptionally precise test identifies the ß-hCG pregnancy hormone in saliva, empowering women to conduct early pregnancy detection at any location and moment, simultaneously facilitating a more private and shareable testing process.

Which Leading Firms Are Contributing To The Growth Of The Rapid Diagnostic Test Kits Market?

Major companies operating in the rapid diagnostic test kits market are F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Hologic Inc, bioMerieux SA, QuidelOrtho Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Cepheid Inc, OraSure Technologies Inc, Nova Biomedical Corporation, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, ACON Laboratories Inc, Fluxergy LLC, Lumos Diagnostics Holdings Limited, Abingdon Health plc, Abionic SA

Read the full rapid diagnostic test kits market report here:

https://www.thebusinessresearchcompany.com/report/rapid-diagnostic-test-kits-global-market-report

Which Regions Are Projected To Dominate The Rapid Diagnostic Test Kits Market In The Coming Years?

North America was the largest region in the rapid diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Rapid Diagnostic Test Kits Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24678&type=smp

Browse Through More Reports Similar to the Global Rapid Diagnostic Test Kits Market 2026, By The Business Research Company

Single Dose Radiotherapy Services Global Market Report

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Image Guided Radiation Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/image-guided-radiation-therapy-global-market-report

Medical Irradiation Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795